Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002042077-25-000016
Filing Date
2025-12-01
Accepted
2025-12-01 14:31:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4606
  Complete submission text file 0002042077-25-000016.txt   6347
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91725 | Film No.: 251539038
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6222 INDIANWOOD TR. BLOOMFIELD HILLS MI 48301
Business Address
Chernett Jorey (Filed by) CIK: 0002042077 (see all company filings)

Type: SCHEDULE 13G